BWFA
TPI

Baltimore-Washington Financial Advisors’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,100
Closed -$3K – 324
2014
Q3 		$3K Hold
5,100
– – ﹤0.01% 260
2014
Q2 		$4K Hold
5,100
– – ﹤0.01% 263
2014
Q1 		$5K Hold
5,100
– – ﹤0.01% 214
2013
Q4 		$4K Buy
+5,100
New +$4.68K ﹤0.01% 257

Other funds holding TPI

PAM
Pope Asset Management Memphis, Tennessee $162M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Baltimore-Washington Financial Advisors's TPI Position: Q4 2014 in Review

Baltimore-Washington Financial Advisors sold out of TIANYIN PHARMACEUTICAL (TPI) in Q4 2014, closing a stake of 5,100 shares — an estimated $3K sold.

Baltimore-Washington Financial Advisors first reported a position in TPI in Q4 2013 and held it in 4 quarters. The position peaked at $5K in Q1 2014. 8 funds tracked by Wall St. Rank hold TPI as of Q4 2014.

  • Baltimore-Washington Financial Advisors reported no remaining TIANYIN PHARMACEUTICAL position as of Q4 2014 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 5,100 TIANYIN PHARMACEUTICAL shares in Q4 2014, an estimated $3K.
  • Baltimore-Washington Financial Advisors first reported a position in TIANYIN PHARMACEUTICAL in Q4 2013 and held it in 4 quarters.
  • Baltimore-Washington Financial Advisors's TIANYIN PHARMACEUTICAL position peaked at $5K in Q1 2014.
  • 8 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q4 2014.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2014, filed 21 Jan 2015.